Andere talen Cassava Sciences, Inc.

Aandelen

SAVA

US14817C1071

Geschatte realtime Cboe BZX Andere beurzen 20:23:01 01-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
22,08 ^USD	-0,34%		+6,70%	-1,69%

25/03	Cassava Sciences kondigt de voltooiing aan van een tussentijdse veiligheidsbeoordeling voor Simufilam, een kandidaat voor de ziekte van Alzheimer	MT
25/03	Cassava Sciences, Inc. Kondigt de voltooiing aan van een tussentijdse veiligheidsbeoordeling van orale Simufilam in lopende Fase 3 studies	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Tomorrow is Last Day to Trade SAVAW Warrants on NASDAQ	15:10
North American Morning Briefing : Investors Brace -2-	29/04
Cassava Sciences : Corporate Presentation – Second Quarter 2024	24/04
Cassava Sciences, Inc. - Redemption Date Announced for Warrants	16/04
Redemption Date Announced for Warrants	15/04
Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cassava	29/03
ROSEN, A LONGSTANDING LAW FIRM, Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before Important April 2 Deadline in Securities Class Action - SAVA	27/03
Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Cassava Sciences, Inc. of Class Action Lawsuit and Upcoming Deadlines - SAVA	27/03
Cassava Sciences Announces Completion of Interim Safety Review for Alzheimer's Drug Candidate Simufilam	25/03
Cassava Sciences : Corporate Presentation – First Quarter 2024	25/03
Cassava Sciences Announces Completion of an Interim Safety Review of Oral Simufilam On-going Phase 3 Trials	25/03
Cassava Sciences, Inc. Announces Completion of an Interim Safety Review of Oral Simufilam On-Going Phase 3 Trials	25/03
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cassava	21/03
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SAVA	20/03
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SAVA	19/03
Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Cassava Sciences, Inc. of Class Action Lawsuit and Upcoming Deadlines - SAVA	19/03
ROSEN, A TOP RANKED LAW FIRM, Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SAVA	17/03
ROSEN, A LEADING LAW FIRM, Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SAVA	15/03
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cassava	13/03
Thinking about buying stock in Lexicon Pharmaceuticals, Cassava Sciences, Clearside Biomedical, Lantern Pharma, or ATAI Life Sciences?	13/03

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Cassava Sciences, Inc.

Aandelen

SAVA

US14817C1071

Andere talen

Filters